Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Non-Current Liabilities (2018 - 2020)

Nephros has reported Total Non-Current Liabilities over the past 9 years, most recently at -$5.3 million for Q4 2020.

  • Quarterly results put Total Non-Current Liabilities at -$5.3 million for Q4 2020, down 245.93% from a year ago — trailing twelve months through Dec 2020 was -$5.3 million (down 245.93% YoY), and the annual figure for FY2020 was -$5.3 million, down 245.93%.
  • Total Non-Current Liabilities for Q4 2020 was -$5.3 million at Nephros, down from $3.8 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for NEPH hit a ceiling of $5.0 million in Q2 2019 and a floor of -$5.3 million in Q4 2020.
  • Median Total Non-Current Liabilities over the past 3 years was $4.2 million (2020), compared with a mean of $3.2 million.
  • Biggest five-year swings in Total Non-Current Liabilities: rose 4.09% in 2019 and later plummeted 245.93% in 2020.
  • Nephros' Total Non-Current Liabilities stood at $3.5 million in 2018, then increased by 4.09% to $3.6 million in 2019, then plummeted by 245.93% to -$5.3 million in 2020.
  • The last three reported values for Total Non-Current Liabilities were -$5.3 million (Q4 2020), $3.8 million (Q3 2020), and $4.2 million (Q2 2020) per Business Quant data.